Workflow
网络安全技术
icon
Search documents
腾讯音乐娱乐申请风险预测方法专利,提高风险预测准确性
Jin Rong Jie· 2026-01-19 12:45
国家知识产权局信息显示,腾讯音乐娱乐科技(深圳)有限公司申请一项名为"一种风险预测方法、装 置、设备及计算机可读存储介质"的专利,公开号CN121356915A,申请日期为2025年12月。 天眼查资料显示,腾讯音乐娱乐科技(深圳)有限公司,成立于2017年,位于深圳市,是一家以从事软 件和信息技术服务业为主的企业。企业注册资本500万人民币。通过天眼查大数据分析,腾讯音乐娱乐 科技(深圳)有限公司共对外投资了12家企业,参与招投标项目14次,财产线索方面有商标信息1169 条,专利信息1457条,此外企业还拥有行政许可45个。 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 本文源自:市场资讯 作者:情报员 专利摘要显示,本发明公开了一种风险预测方法、装置、设备及计算机可读存储介质,应用于网络安全 技术领域,包括:确定目标网络场景中的目标静态风险特征对应的第一未来处置比、目标关联网络风险 特征对应的第二未来处置比;基于第一特征命中次数和第一未来处置比确定目标用户对应的静态风险 分,基于第二命中次数和第二未来处置比确定目标用户对应的关联网络风险分;基于目标静态风险特 ...
安博通获2025“上证鹰·金质量”科技创新奖
Xin Lang Cai Jing· 2025-12-08 12:25
Core Insights - Anbotong won the "Shangzheng Eagle·Golden Quality" Technology Innovation Award at the 2025 Shangzheng (Chao Lake) High-Quality Development Conference, highlighting the capital market's recognition of the company's technology-driven high-quality development [1][3] - The company is the first cybersecurity firm to be listed on the Sci-Tech Innovation Board and is recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise [1][3] - Anbotong has established a robust R&D system with centers in Beijing, Wuhan, and Shanghai, and has created the "Luban" AI Research Institute, developing a comprehensive product matrix covering various security domains [1][3] Strategic Direction - During a large investor communication event, Anbotong announced its strategic upgrade from being a "visual network security technology innovator" to an "AI era security computing power ecosystem builder," signaling a clear strategic positioning and long-term investment value [2][4] - The event attracted over a hundred representatives from major domestic investment institutions, sell-side analysts, and industry professionals, indicating strong market interest [2][4]
工行取得应用于网络靶场的仿真推演方法、装置、设备和介质专利
Sou Hu Cai Jing· 2025-12-06 04:44
Group 1 - The core point of the article is that the Industrial and Commercial Bank of China (ICBC) has obtained a patent for a method, device, and medium for simulation in a network test environment, with the patent granted under announcement number CN119316172B and the application date being May 2024 [1] Group 2 - ICBC was established in 1985 and is located in Beijing, primarily engaged in monetary financial services [1] - The registered capital of ICBC is approximately 35.64 billion RMB [1] - According to data analysis, ICBC has invested in 28 companies, participated in 5,000 bidding projects, holds 988 trademark records, and has 5,000 patent records, along with 77 administrative licenses [1]
佳华科技拟购数盾科技有望切入高速加密技术赛道
Core Viewpoint - JiaHua Technology plans to acquire a controlling stake in Shudun Technology through a combination of issuing shares and cash payment, which may constitute a significant asset restructuring [2][3] Group 1: Acquisition Details - The acquisition involves signing a share purchase intention agreement with Shudun Technology's major shareholder, Zhu Yun, with the final price to be determined by a qualified appraisal [3] - The transaction is still in negotiation, and the final counterparties will be disclosed in future announcements [3] - The acquisition will not lead to a change in the actual controller of JiaHua Technology [3] Group 2: Shudun Technology Overview - Shudun Technology, established in 2002, specializes in domestic password technology research and has received recognition from the National Cryptography Administration [4] - The company has developed four major systems: password security products, information security products, compliance services, and cryptographic evaluation services [4] - Shudun Technology has obtained 23 commercial password product certificates, 30 patents, and 90 software copyrights, and has established a research institute in collaboration with Peking University [4] Group 3: JiaHua Technology's Financial Performance - JiaHua Technology has faced continuous losses since 2021, with total revenues declining from 486 million yuan in 2021 to 300 million yuan in 2024 [5] - The net profit attributable to shareholders has also been negative, with figures of -129 million yuan in 2021 and -67 million yuan in the first three quarters of 2025 [5][6] - The company attributes its performance issues to reduced customer demand and intensified market competition, particularly affecting its government and state-owned enterprise clients [5][6] Group 4: Future Strategies - To improve its financial situation, JiaHua Technology plans to focus on cost reduction, revenue increase, and efficiency enhancement [6] - The company aims to optimize resource allocation, reduce non-core R&D spending, and enhance management processes through digitalization [6] - Revenue growth will be pursued through project delivery and promoting a green low-carbon management platform [6] Group 5: Market Capitalization - As of November 21, JiaHua Technology's total market capitalization was 3.712 billion yuan [7]
【2025数博会】AI看数博会黑科技②
Sou Hu Cai Jing· 2025-08-14 05:38
Group 1 - The article discusses various innovative technologies showcased at the Data Expo, highlighting advancements in artificial intelligence and user interaction [1][22] - Xiaomi's AI assistant, Xiao Ai, integrates with smart devices to provide personalized services through voice commands, enhancing user experience [4] - JD.com's 3D product display technology allows users to interact with products in a virtual environment, improving online shopping experiences [8] Group 2 - Flexible display technology, introduced at the expo, offers design freedom and superior image quality, applicable in various devices from smartphones to medical equipment [13] - The 360 Smart Firewall utilizes AI to enhance network security by detecting threats and providing a user-friendly management interface [17] - Super microcomputers, a cutting-edge concept, leverage tiny computing units for efficient energy use and potential applications in health monitoring and environmental sensing [21] Group 3 - Big data genetic prediction technology analyzes genomic data to forecast individual health risks and responses to medications, promoting personalized healthcare [27]